Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care Subtitle: Cardiac Dysfunction in Older Sepsis Survivors Subtitle: Development of a Designer Proline-Rich Antimicrobial Peptide Chaperone Protein Inhibitor (DPC) for Treating Sepsis

NCT02276417 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT02276417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02276417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS): A New Horizon for Surgical Critical Care Subtitle: Cardiac Dysfunction in Older Sepsis Survivors Subtitle: Development of a Designer Proline-Rich Antimicrobial Peptide Chaperone Protein Inhibitor (DPC) for Treating Sepsis
Lead sponsor
University of Florida
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 2015
Completion date
July 24, 2027
Enrollment
668 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis